• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hyperlipidaemia and cardioprotection: Animal models for translational studies.高脂血症与心脏保护:转化研究的动物模型。
Br J Pharmacol. 2020 Dec;177(23):5287-5311. doi: 10.1111/bph.14931. Epub 2020 Jan 17.
2
Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.高胆固醇血症对心肌功能、缺血-再灌注损伤以及预处理、后处理和远程预处理的心脏保护作用的影响。
Br J Pharmacol. 2017 Jun;174(12):1555-1569. doi: 10.1111/bph.13704. Epub 2017 Feb 8.
3
Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options.感觉神经病变情况下的心肌缺血再灌注损伤与心脏保护:治疗选择
Br J Pharmacol. 2020 Dec;177(23):5336-5356. doi: 10.1111/bph.15021. Epub 2020 Mar 21.
4
Effect of hyperglycaemia and diabetes on acute myocardial ischaemia-reperfusion injury and cardioprotection by ischaemic conditioning protocols.高血糖和糖尿病对急性心肌缺血再灌注损伤及缺血预处理保护作用的影响。
Br J Pharmacol. 2020 Dec;177(23):5312-5335. doi: 10.1111/bph.14993. Epub 2020 Mar 9.
5
Ageing, sex, and cardioprotection.衰老、性别与心脏保护
Br J Pharmacol. 2020 Dec;177(23):5270-5286. doi: 10.1111/bph.14951. Epub 2020 Feb 3.
6
Cardioprotection in right heart failure.右心衰竭中的心肌保护。
Br J Pharmacol. 2020 Dec;177(23):5413-5431. doi: 10.1111/bph.14992. Epub 2020 Mar 9.
7
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.心血管不可变风险因素、合并症和合并用药与缺血/再灌注损伤的相互作用,以及药物治疗和缺血预处理的心脏保护作用。
Pharmacol Rev. 2023 Jan;75(1):159-216. doi: 10.1124/pharmrev.121.000348. Epub 2022 Dec 8.
8
Co-morbidities and co-medications as confounders of cardioprotection-Does it matter in the clinical setting?合并症和联合用药作为心脏保护的混杂因素——在临床环境中这重要吗?
Br J Pharmacol. 2020 Dec;177(23):5252-5269. doi: 10.1111/bph.14839. Epub 2020 Jan 3.
9
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.心血管危险因素与心肌缺血/再灌注损伤、预处理及后处理之间的相互作用。
Pharmacol Rev. 2007 Dec;59(4):418-58. doi: 10.1124/pr.107.06002. Epub 2007 Nov 29.
10
Preconditioning and postconditioning: underlying mechanisms and clinical application.预处理和后处理:潜在机制与临床应用。
Atherosclerosis. 2009 Jun;204(2):334-41. doi: 10.1016/j.atherosclerosis.2008.10.029. Epub 2008 Nov 5.

引用本文的文献

1
Current status and challenges of multi-omics research using animal models of atherosclerosis.使用动脉粥样硬化动物模型进行多组学研究的现状与挑战
J Mol Cell Cardiol Plus. 2025 Jul 10;13:100476. doi: 10.1016/j.jmccpl.2025.100476. eCollection 2025 Sep.
2
Early-Life Prevention of Cardiovascular-Kidney-Metabolic Syndrome: The DOHaD Perspective on Resveratrol and Short-Chain Fatty Acids.心血管-肾脏-代谢综合征的早期预防:发育起源健康与疾病(DOHaD)视角下的白藜芦醇和短链脂肪酸
Antioxidants (Basel). 2025 Jul 10;14(7):851. doi: 10.3390/antiox14070851.
3
Preventive, ameliorative, and therapeutic effects of steamed mature silkworms on metabolic disorders caused by loss of apolipoprotein E.蒸制熟蚕对载脂蛋白E缺失所致代谢紊乱的预防、改善及治疗作用
NPJ Sci Food. 2025 Feb 25;9(1):27. doi: 10.1038/s41538-025-00392-0.
4
Antiplatelet Effects of a Combination of Sappan Wood ( L.) and Red Ginger () Extracts in a High-Fat Diet-Induced Rat Model.苏木(Caesalpinia sappan L.)与红姜(Zingiber officinale)提取物组合在高脂饮食诱导的大鼠模型中的抗血小板作用
Adv Pharmacol Pharm Sci. 2024 Dec 20;2024:5543717. doi: 10.1155/adpp/5543717. eCollection 2024.
5
Whole blood gene expression analysis of spontaneous hypertriglyceridemia in dogs suggests an underlying pro-thrombotic process.犬自发性高甘油三酯血症的全血基因表达分析提示存在潜在的促血栓形成过程。
PLoS One. 2024 Nov 12;19(11):e0313343. doi: 10.1371/journal.pone.0313343. eCollection 2024.
6
Harnessing the power of bioprinting for the development of next-generation models of thrombosis.利用生物打印技术的力量开发下一代血栓形成模型。
Bioact Mater. 2024 Sep 5;42:328-344. doi: 10.1016/j.bioactmat.2024.08.040. eCollection 2024 Dec.
7
The Influence of Metabolic Risk Factors on the Inflammatory Response Triggered by Myocardial Infarction: Bridging Pathophysiology to Treatment.代谢风险因素对心肌梗死后炎症反应的影响:将病理生理学与治疗联系起来。
Cells. 2024 Jun 29;13(13):1125. doi: 10.3390/cells13131125.
8
Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review).PCSK9 在各种代谢状态下对血栓形成和止血的影响:脂质及其他(综述)。
Int J Mol Med. 2024 Jun;53(6). doi: 10.3892/ijmm.2024.5381. Epub 2024 May 17.
9
Fatty Acid-Binding Proteins Identification during the Evolution of Metabolic Syndrome: A Raman Spectroscopy-Based Approach.基于拉曼光谱的代谢综合征演化过程中脂肪酸结合蛋白的鉴定。
Molecules. 2023 Nov 8;28(22):7472. doi: 10.3390/molecules28227472.
10
High-Fat Diet Enhances Platelet Activation and Is Associated with Proprotein Convertase Subtilisin Kexin 9: An Animal Study.高脂饮食增强血小板活化,并与前蛋白转化酶枯草溶菌素 9 相关:一项动物研究。
Nutrients. 2023 Oct 21;15(20):4463. doi: 10.3390/nu15204463.

本文引用的文献

1
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets.2019/20 年简明药理学指南:引言和其他蛋白靶点。
Br J Pharmacol. 2019 Dec;176 Suppl 1(Suppl 1):S1-S20. doi: 10.1111/bph.14747.
2
HDL protects against myocardial ischemia reperfusion injury via miR-34b and miR-337 expression which requires STAT3.HDL 通过 miR-34b 和 miR-337 的表达来保护心肌缺血再灌注损伤,这需要 STAT3。
PLoS One. 2019 Jun 20;14(6):e0218432. doi: 10.1371/journal.pone.0218432. eCollection 2019.
3
Hypercholesterolemia antagonized heart adaptation and functional remodeling of the mitochondria observed in acute diabetes mellitus subjected to ischemia/reperfusion injury.高胆固醇血症拮抗了急性糖尿病缺血/再灌注损伤时所观察到的心脏适应性和线粒体功能重塑。
J Physiol Pharmacol. 2018 Oct;69(5). doi: 10.26402/jpp.2018.5.03. Epub 2019 Jan 21.
4
Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages.载脂蛋白 A1(ABCA1)介导的胆固醇外排受巨噬细胞中鞘氨醇-1-磷酸信号的调节。
J Lipid Res. 2019 Mar;60(3):506-515. doi: 10.1194/jlr.M088443. Epub 2019 Jan 17.
5
Adverse interaction between HDL and the mass of myocardial infarction.高密度脂蛋白与心肌梗死质量的不良相互作用。
Atherosclerosis. 2019 Feb;281:9-16. doi: 10.1016/j.atherosclerosis.2018.12.002. Epub 2018 Dec 6.
6
Anti-Atherosclerotic Effect of a Polyphenol-Rich Ingredient, Oleactiv, in a Hypercholesterolemia-Induced Hamster Model.多酚丰富成分 Oleactiv 在高胆固醇血症诱导的仓鼠模型中的抗动脉粥样硬化作用。
Nutrients. 2018 Oct 15;10(10):1511. doi: 10.3390/nu10101511.
7
Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs.载脂蛋白 E 缺乏加速小型猪动脉粥样硬化的发展。
Dis Model Mech. 2018 Oct 10;11(10):dmm036632. doi: 10.1242/dmm.036632.
8
Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7.缺乏低密度脂蛋白受体 (LDLR) 外显子 7 的兔自发性严重高胆固醇血症和动脉粥样硬化病变。
EBioMedicine. 2018 Oct;36:29-38. doi: 10.1016/j.ebiom.2018.09.020. Epub 2018 Sep 19.
9
Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy.高密度脂蛋白(HDL)通过 HDL-S1P 介导的血管平滑肌细胞中的强效抗炎特性及其因 HDL-S1P 降低导致的冠心病损害:HDL 功能障碍及其治疗的一个新方面。
FASEB J. 2019 Jan;33(1):1482-1495. doi: 10.1096/fj.201801245R. Epub 2018 Aug 21.
10
Reduction in Secretion of Very Low Density Lipoprotein-Triacylglycerol by a Matrix Metalloproteinase Inhibitor in a Rat Model of Diet-Induced Hypertriglyceridemia.基质金属蛋白酶抑制剂在饮食诱导的高甘油三酯血症大鼠模型中降低极低密度脂蛋白-三酰甘油的分泌。
J Pharmacol Exp Ther. 2018 Jul;366(1):194-204. doi: 10.1124/jpet.117.246165. Epub 2018 May 7.

高脂血症与心脏保护:转化研究的动物模型。

Hyperlipidaemia and cardioprotection: Animal models for translational studies.

机构信息

Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.

Institute for Physiology, Justus-Liebig University Giessen, Giessen, Germany.

出版信息

Br J Pharmacol. 2020 Dec;177(23):5287-5311. doi: 10.1111/bph.14931. Epub 2020 Jan 17.

DOI:10.1111/bph.14931
PMID:31769007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7680007/
Abstract

Hyperlipidaemia is a well-established risk factor for cardiovascular diseases and therefore, many animal model have been developed to mimic the human abnormal elevation of blood lipid levels. In parallel, extensive research for the alleviation of ischaemia/reperfusion injury has revealed that hyperlipidaemia is a major co-morbidity that attenuates the cardioprotective effect of conditioning strategies (preconditioning, postconditioning and remote conditioning) and that of pharmacological interventions by interfering with cardioprotective signalling pathways. In the present review article, we summarize the existing data on animal models of hypercholesterolaemia (total, low density and HDL abnormalities) and hypertriglyceridaemia used in ischaemia/reperfusion injury and protection from it. We also provide recommendations on preclinical animal models to be used for translations of the cardioprotective strategies into clinical practice. LINKED ARTICLES: This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.23/issuetoc.

摘要

高脂血症是心血管疾病的一个明确的危险因素,因此,许多动物模型被开发出来以模拟人类血液脂质水平的异常升高。与此同时,为了缓解缺血/再灌注损伤而进行的广泛研究表明,高脂血症是一种主要的合并症,它通过干扰心脏保护信号通路,减弱了预处理、后处理和远程预处理等条件策略以及药物干预的心脏保护作用。在这篇综述文章中,我们总结了用于缺血/再灌注损伤及其保护的动物模型中存在的高胆固醇血症(总胆固醇、低密度脂蛋白和高密度脂蛋白异常)和高三酰甘油血症的数据。我们还就临床前动物模型提出了建议,以将心脏保护策略转化为临床实践。

相关文章

本文是心脏保护中的危险因素、合并症和合并用药专题的一部分。要查看该部分的其他文章,请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.23/issuetoc.